A precursor form of PSA (pPSA) is a component of the free PSA in prostate cancer serum

Urology

Volumn 50, Issue 5, 1997, Pages 710-714

  Mikolajczyk, Stephen D ^a,b   Grauer, Lana S ^a   Millar, Lisa S ^a   Hill, Timothy M ^a   Kumar, Abhay ^a   Rittenhouse, Harry G ^a   Wolfert, Robert L ^a   Saedi, Mohammad S ^a  

^a Hybritech Incorporated   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ARTICLE; CANCER SCREENING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOBLOTTING; MALE; PRIORITY JOURNAL; PROSTATE CANCER; SEMINAL PLASMA; SERUM;

HUMANS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROTEIN PRECURSORS;

EID: 0030715051     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(97)00449-4     Document Type: Article

References (22)

1. Brawer MK, Chetner MP, Beatie J, Buchner DM, Vessella RL, and Lange PH: Screening for prostate carcinoma with prostate specific antigen. J Urol 147(3 Pt 2): 841-845, 1992.
2. Catalona WJ, Smith DS, Ratliff TL, Dodds KM, Coplen DE, Yuan JJ, Tetros JA, and Andriole GL: Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 324: 1156-1161, 1991.
3. Labrie F, Dupont A, Suburu R, Cusan L, Tremblay M, Gomez J-L, and Emond J: Serum prostate specific antigen as pre-screening test for prostate cancer. J Urol 147 (3 Pt 2): 846-852, 1992.
4. Watt KWK, Lee P-J, M'Timkulu T, Chan W-P, and Loor R: Human prostate-specific antigen: structural and functional similarity with serine proteases. Proc Natl Acad Sci USA 83: 3166-3170, 1986.
5. Bridon DP, and Dowell BL: Structural comparison of prostate-specific antigen and human glandular kallikrein using molecular modeling. Urology 45: 801-806, 1995.
6. Villoutreix BO, Getzoff ED, and Griffin JH: A structural model for the prostate disease marker, human prostate-specific antigen. Protein Sci 3: 2033-2044, 1994.
7. Christensson A, Laurell C-B, and Lilja H: Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors. Eur J Biochem 194: 755-763, 1990.
8. Lilja H, Christensson A, Dahlen U, Matikainen M-T, Nilsson O, Pettersson K, and Lovgren T: Prostate-specific antigen in serum occurs predominantly in complex with alpha-1-antichymotrypsin. Clin Chem 37: 1618-1625, 1991.
9. Stenman UH, Leinonen J, Alfthan H, Rannikko S, Tuhkanen K, and Alfthan O: A complex between prostate specific antigen and alpha-1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res 51: 222-226, 1991.
10. Christensson A, Bjork T, Nilsson O, Dahlen U, Matikainen T, Cockett A, Abrahamsson P-A, and Lilja H: Serum prostate specific antigen complexed to alpha-1-antichymotrypsin as an indicator of prostate cancer. J Urol 150: 100-105, 1993.
11. Catalona WJ: Clinical utility of measurements of free and total prostate-specific antigen (PSA): a review. Prostate Suppl 7: 64-69, 1996.
12. van Iersel MP, Witjes WPJ, Thomas CMG, Segers MFG, Oosterhoff GON, and Debruyne FMJ: Review on the simultaneous determination of total prostate-specific antigen and free prostate-specific antigen. Prostate 7(suppl): 48-57, 1996.
13. Chen Z, Chen H, and Stamey TA: Prostate specific antigen in benign prostatic hyperplasia: purification and characterization. J Urol 157: 2166-2170, 1997.
14. Kumar A, Goel A, Hill T, Mikolajczyk S, Millar L, Kuus-Reichel K, and Saedi M: Expression of human glandular kallikrein, hK2, in mammalian cells. Cancer Res 56: 5397-5402, 1996.
15. Kumar A, Mikolajczyk SD, Goel AS, Millar LS, and Saedi MS: Expression of pro form of prostate-specific antigen by mammalian cells and its conversion to mature, active form by human kallikrein 2. Cancer Res 57: 3111-3114, 1997.
16. Wang TJ, Linton HJ, Sokoloff RL, Grauer LS, Rittenhouse HG, and Wolfert RL: Antibody specificities for PSA and PSA fragments by SDS-PAGE Western blot analysis. Tumor Biol (in press).
17. Mikolajczyk SD, Millar LS, Marker KM, Grauer LS, Goel AS, Cass MMJ, Kumar A, and Saedi MS: Ala217 is important for the catalytic function and autoactivation of prostate-specific human kallikrein 2. Eur J Biochem 246: 440-446, 1997.
18. Qian Y, Sensibar JA, Zelner DJ, Schaeffer AJ, Finlay JA, Rittenhouse HG, and Lee C: Two-dimensional gel electrophoresis detects prostate-specific antigen-alpha-1-antichymotrypsin complex in serum but not in prostatic fluid. Clin Chem 43: 352-359, 1997.
19. Zhang W-M, Leinonen J, Kalkkinen N, Dowell B, and Stenman U-H: Purification and characterization of different molecular forms of prostate-specific antigen in human seminal fluid. Clin Chem 41: 1567-1573, 1995.
20. Saedi MS, Hill TM, Goel AS, and Kumar A: Assessment of the precursor form of human glandular kallikrein (pro hK2) as marker for prostate cancer (abstract). J Urol 157(suppl): 442, 1997.
21. Tremblay RR, Deperthes D, Tétu B, and Dubé JY: Immunohistochemical study suggesting a complementary role of kallikreins hK2 and hK3 (PSA) in the functional analysis of human prostate tumors. Am J Pathol 15: 455-459, 1997.
22. Darson MF, Parcelli A, Roche P, Rittenhouse HG, Wolfert RL, Young CYF, Klee GG, Tindall DJ, and Bostwick DG: Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker. Urology 49: 857-862, 1997.